A man in his 40s of Middle Eastern descent, with no prior medical history, presented with severe abdominal pain that had ...
Rilparencel, a percutaneous minimally invasive injectable product prepared from patients’ own kidney cells, is being developed to treat those with stage 3b or 4 CKD and either type 1 or type 2 ...
Povetacicept is an investigational dual BAFF and APRIL inhibitor being tested for various glomerulonephritis types in clinical trials.
Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback